Tech24 Deals Web Search

Search results

1. Results from the Tech24 Deals Content Network

2. Sibutramine - Wikipedia

   en.wikipedia.org/wiki/Sibutramine

   Sibutramine is a serotonin–norepinephrine reuptake inhibitor (SNRI) that, in humans, reduces the reuptake of norepinephrine (by ~73%), serotonin (by ~54%), and dopamine (by ~16%), [ 22] thereby increasing the levels of these substances in synaptic clefts and helping enhance satiety; the serotonergic action, in particular, is thought to ...

3. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   t. e. Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes ...

4. A comprehensive history of weight loss drugs through the ...

   www.aol.com/comprehensive-history-weight-loss...

   In 1997, the FDA approved the weight loss drug Meridia (sibutramine hydrochloride monohydrate). But Meridia lost the FDA's blessing when clinical trial data linked the drug to an increased risk of ...

5. Serotonin–norepinephrine reuptake inhibitor - Wikipedia

   en.wikipedia.org/wiki/Serotonin–norepinephrine...

   Meridia: Obesity [15] 1997: An SNRI, which, instead of being developed for the treatment of depression, was widely marketed as an appetite suppressant for weight loss purposes. Sibutramine was the first drug for the treatment of obesity to be approved in 30 years. [16]

6. US FDA warns website over unlawful sale of weight-loss drugs

   www.aol.com/news/us-fda-warns-website-over...

   July 2, 2024 at 10:05 AM. (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had warned a website called ozempen.com against unlawfully selling versions of Novo Nordisk's weight ...

7. Abbott Pulls Weight Loss Drug Meridia from the Market - AOL

   www.aol.com/2010/10/08/abbott-weight-loss-drug...

   Drug and medical-device maker Abbott Laboratories (ABT) announced Friday that it will voluntarily withdraw its controversial obesity drug Meridia, (sibutramine) from the U.S. market at the request ...